|
XPO5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.268000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.949000E-01 |
| Normal-vs-Stage2 |
1.429570E-01 |
| Normal-vs-Stage3 |
8.680600E-01 |
| Normal-vs-Stage4 |
9.213200E-01 |
| Stage1-vs-Stage2 |
2.924200E-01 |
| Stage1-vs-Stage3 |
2.585600E-01 |
| Stage1-vs-Stage4 |
4.935000E-01 |
| Stage2-vs-Stage3 |
7.584400E-02 |
| Stage2-vs-Stage4 |
1.752190E-01 |
| Stage3-vs-Stage4 |
7.961400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.197200E-01 |
| Normal-vs-AfricanAmerican |
1.398420E-01 |
| Normal-vs-Asian |
7.463400E-01 |
| Caucasian-vs-AfricanAmerican |
3.182000E-01 |
| Caucasian-vs-Asian |
8.907000E-01 |
| AfricanAmerican-vs-Asian |
3.055400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.892200E-01 |
| Normal-vs-Female |
2.016200E-01 |
| Male-vs-Female |
4.067700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.666400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.028200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.370800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.554200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.293000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.697200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.267800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.992000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.158000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.367000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.251200E-01 |
| Classical-VS-Follicular |
9.129800E-02 |
| Classical-VS-Other |
8.529600E-02 |
| Classical-VS-Normal |
1.177800E-01 |
| Tall-VS-Follicular |
9.405400E-01 |
| Tall-VS-Other |
1.917350E-01 |
| Tall-VS-Normal |
8.258400E-01 |
| Follicular-VS-Other |
3.211800E-01 |
| Follicular-VS-Normal |
8.803000E-01 |
| Other-VS-Normal |
1.260230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.355000E-01 |
| Normal-vs-N1 |
2.399600E-01 |
| N0-vs-N1 |
7.205900E-02 |
|
|
